copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Novartis AG and Subsidiaries to Pay $345 Million to Resolve . . . NEWARK, N J – Switzerland-based global pharmaceutical company Novartis AG and a current and former subsidiary will pay $345 million in criminal and regulatory penalties to resolve violations of the Foreign Corrupt Practices Act (FCPA), U S Attorney Craig Carpenito, Assistant Attorney General Brian A Benczkowski of the Justice Department’s Cri
Novartis’ FCPA Settlement and New Compliance Guidance In late June, the U S Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) announced that Novartis AG and Alcon Pte Ltd, a former subsidiary of the Swiss drug maker, agreed to pay a combined $347 million to resolve allegations that the companies engaged in corrupt conspiracies to bribe public hospitals and
SEC Charges Novartis AG with FCPA Violations Novartis agreed to pay disgorgement of $92 3 million and $20 5 million in prejudgment interest and to comply with a three-year undertaking to self-report on the status of its remediation and implementation of compliance measures